EUCTR2005-001306-87-IT进行中（未招募）不适用
EFFECTS OF CANDESARTAN CILEXETIL VS STANDARD THERAPY ON SERUM LEVELS OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS SUFFERING FROM CHRONIC HEART FAILURE WITH DEPRESSED AND PRESERVED SYSTOLIC FUNCTIO
TAKEDA0 个研究点目标入组 1,500 人开始时间: 2007年2月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
未知
3 期
Double Blind Study of TCV-116 in Patients with HypertensioJPRN-jRCT2080221017Takeda Pharmaceutical Company Limited
终止
3 期
Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureHeart FailureNCT00843154Takeda571
进行中（未招募）
1 期
Comparative Effects of Telmisartan and Candesartan on glucose metabolism in patients with chronic heart failure - Sartans and glucosemetabolismEUCTR2005-002109-22-ATMedical University of Vienna99
已完成
不适用
Effects of Telmisartan compared with Candesartan on ischemic cardiovascular events in high-risk hypertensive patients: a multi-center, prospective, randomized, open-labeled, blinded endpoints trialEssential hypertensionJPRN-UMIN000001762Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine1,500
已完成
3 期
DIabetic Retinopathy Candesartan TrialsType 2 DiabetesNCT00252694AstraZeneca4,717